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Introduction: Asthma Control Questionnaire (ACQ) is a validated tool to measure asthma control. Cut-off points
that best discriminate “well-controlled” or “not well-controlled” asthma have been suggested from the analysis of a
large randomized clinical trial but they may not be adequate for daily clinical practice.
Aims: To establish cut-off points of the ACQ that best discriminate the level of control according to Global Initiative
for Asthma (GINA) 2006 guidelines in patients with asthma managed at Allergology and Pulmonology Departments
as well as Primary Care Centers in Spain.
Patients and methods: An epidemiological descriptive study, with prospective data collection. Asthma control
following GINA-2006 classification and 7-item ACQ was assessed. The study population was split in two parts: 2/3
for finding the cut-off points (development population) and 1/3 for validating the results (validation population).
Results: A total of 1,363 stable asthmatic patients were included (mean age 38 ± 14 years, 60.3% women; 69.1%
non-smokers). Patient classification according to GINA-defined asthma control was: controlled 13.6%, partially
controlled 34.2%, and uncontrolled 52.3%. The ACQ cut-off points that better agreed with GINA-defined asthma
control categories were calculated using receiver operating curves (ROC). The analysis showed that ACQ< 0.5 was
the optimal cut-off point for “controlled asthma” (sensitivity 74.1%, specificity 77.5%) and 1.00 for “uncontrolled
asthma” (sensitivity 73%, specificity 88.2%). Kappa index between GINA categories and ACQ was 0.62 (p< 0.001).
Conclusion: The ACQ cut-off points associated with GINA-defined asthma control in a real-life setting were <0.5
for controlled asthma and ≥1 for uncontrolled asthma.
Keywords: Asthma control, GINA guidelines, Asthma control questionnaire, Validation studyIntroduction
Asthma is a global health problem that affects around
300 million individuals of all ages, ethnic groups, and
countries [1]. It is estimated that 250,000 people die pre-
maturely each year as a result of asthma [2]. Proper care
of patients with asthma involves the triad of systematic
chronic care plans, self-management support, and ap-
propriate medical therapy [3,4].* Correspondence: berta_julia@merck.com
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reproduction in any medium, provided the orThe Global Initiative for Asthma (GINA), in the 2006
update proposed a new classification of asthma, based
on the level of control rather than the previous classifi-
cation based on the severity of the underlying disease
process [5]. Thus, asthma treatment goal, regardless of
patient's asthma severity, should lead to achievement of
complete disease control. In addition, prevention of fu-
ture risks should also be intended [6,7].
The main limitation of GINA classification of asthma
control is that it is based on an expert consensus, and
has not yet been validated in real world practice [8].
Nevertheless and despite the availability of guidelines, aral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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asthma are not optimally controlled [9-12].
Standardized and validated questionnaires, such as the
Asthma Control Questionnaire (ACQ), help us to assess
the level of asthma control [13]. However, the ACQ cut-
off points previously defined to discriminate between
“well-controlled” and “not well controlled” asthma have
been suggested from the analysis of a large randomized
clinical trial (Gaining Optimal Asthma Control –GOAL-
study), and they may not be adequate for daily clinical
practice [14]. In addition, several variables such as rhin-
itis, exposure to tobacco smoke, obesity and allergen ex-
posure influence as well asthma control [15-17].
The primary aim of the present study was the estab-
lishment of the ACQ cut-off points that best discrimin-
ate the degree of asthma control according to 2006
GINA criteria in a population of patients with asthma
from Allergy and Pulmonology Departments as well as
Primary Care Centers. The secondary aim was to valid-
ate the results obtained from the development popula-
tion in another sample population.
Patients and methods
Study design
Multicenter, epidemiological descriptive study, with pro-
spective data collection. Patients with physician-diagnosed
asthma were consecutively recruited from among those
visiting Allergy and Pulmonology Departments as well
as Primary Care Centers. Each participating physician
selected the first eight patients who met the inclusion cri-
teria during a six month period. Data were collected in a
case report form completed by the physician. Patients
were required to give written informed consent before in-
clusion in the study. The study protocol was approved by
the institutional review board and the study was con-
ducted in accordance with the principles of the Declar-
ation of Helsinki.
Patients
Patients> 12 and< 65 years of age diagnosed with asthma
and with a stable clinical condition* that attended one of
the participant Allergy and Pulmonology Departments or
Primary Care Centers during a six month period were eli-
gible to participate in the study. Other inclusion criteria
included administration of asthma treatment within the
month prior to study inclusion, and absence of any psy-
chological, psychical or language limitation that prevent
the correct completion of the case report form.
Definition of asthma diagnosis
The medical record must contain description of symp-
toms consistent with asthma and objective evidence of
variable airway obstruction, following the diagnostic cri-
teria of GINA guidelines [5]. Additionally a demonstrationof a positive bronchodilator test (increase in FEV1 ≥12%
and 200 mL) on at least one occasion within the previous
year was required.
*Definition of stable clinical condition
Patient had not required hospital admissions, ER visits or
timely use of oral corticosteroids within the last month.
Study aims
Primary aim
The primary aim of the study was the establishment of
cut-off points to discriminate the level of asthma control
(as defined in GINA 2006 guidelines) using the ACQ
questionnaire, in asthmatic patients attending Allergy
and Pulmonology Departments as well as Primary Care
Centers.
GINA-defined asthma control: According to clinical
characteristics that include daytime symptoms, limita-
tions of activity, nocturnal symptoms/awakening, need
for reliever/rescue treatment; lung function (PEF or
FEV1), asthma patients were classified as controlled, par-
tially controlled or uncontrolled [5]. Thereafter, treat-
ment management was based on the level of asthma
control [5].
ACQ: Contains five items scoring symptoms, a ques-
tion about frequency of β2-agonists use and another
about pre-bronchodilator FEV1 (%) (total of seven ques-
tions) [13]. Patients are asked to score how their asthma
has been in the previous 7 days and respond to each
question on a 7-point scale (0 = no impairment; 6 =max-
imum impairment). Scores range between 0 (well con-
trolled) and 6 (extremely poorly controlled). A validated
Spanish version of the questionnaire was used [18]. In
addition, a validated simplified version of the question-
naire (ACQ-5), in which FEV1 and β2-agonist use ques-
tions are excluded from the seven-item ACQ was also
used for analysis [19].
Secondary aim
Validation of the primary aim of the study by performing
the same analysis in a different sample of the patient
population.
Variables analyzed
Patients completed two self-administered questionnaires
(ACQ and Mini Asthma Quality of Life Questionnaire –
MiniAQLQ [13,20]) and answered one question regard-
ing his/her own asthma control perception (well
controlled, partially controlled or uncontrolled asthma)
before entering the physicians’ office. Physicians, who
were blinded to the results of the previous tests, com-
pleted an electronic case report form which recorded
the following patients’ epidemiological and clinical vari-
ables: age, gender, height, weight and BMI (kg/m2)
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tact with animals; prior history of atopic disease, rhinitis,
conjunctivitis, atopic dermatitis, urticaria, food allergy;
family history of atopic disease; time since asthma diag-
nosis; maintenance asthma treatment; number of asthma
exacerbations within the last year; asthma and rhinitis
comorbidity; time since rhinitis diagnosis; severity of
rhinitis according to ARIA classification [15]; treatment
for rhinitis, and other data related to rhinitis, atopy, etc.,
that will be published elsewhere.
In the electronic data collection form, the 6 items
included in the GINA classification of control [5] were
included and analyzed to evaluate the category of con-
trol, which was the comparator or gold standard.
Physicians also gave their own perception of patient’s
level of asthma control (well controlled, partially con-
trolled or uncontrolled asthma).
Statistical analysis
Sample size
The sample size was calculated for a sensitivity and spe-
cificity of at least 75%, with a confidence level of 95%
and a sampling error of 5%. This would require a sample
size of 180 physicians and 8 consecutive medical patients
(total sample: 1,440), with an estimated percentage of
follow up loss of 20%. The results were validated in a
subpopulation of 402 patients.
Statistical analysis
For the description of continuous variables, the mean and
standard deviation, the median and the interquartile range
in the case of asymmetry and the maximum and mini-
mum values observed were used. For the description of
categorical variables, the number and percentage of
patients per response category were used. The qualitative
variables were compared using the chi-squared test and
the quantitative variables using the t-Student test or vari-
ance analysis after study of variance homogeneity. Intra
questionnaire reliability was analyzed with the frequency
for endorsement and the Cronbach’s alpha.
Eligible patients from the entire data base were rando-
mized in a 2:1 manner to create a development and val-
idation datasets, respectively. The development dataset
was initially used for evaluating agreement and deter-
mining de cut-off points for the ACQ associations with
GINA 2006 control classification. The result was tested
in the validation dataset.
The inter-method reliability (asthma control question-
naire and GINA 2006 guidelines) was assessed using the
kappa or weighted ordinal differing weights for ordinal
scores. Receiver operating characteristic (ROC) curves
were built to evaluate the discriminative power of the
ACQ score over the GINA 2006 clinical guidelines. Both
the area under the curve (AUC) and the hypothesistesting were calculated as well as the cut-off points that
discriminated between control and no control. Once the
cut-off point was selected, the convergent validity was
assessed and subsequently compared with ACQ scale
through the combination of sensitivity, specificity, and
positive and negative likelihood ratios. The 95% confi-
dence intervals were estimated for all the parameters.
For the statistical analysis, the SPSS version 15 for
Windows statistical package was used. A level of statis-




From January 2009 to July 2009 a total of 1,392 patients
from 180 Allergy (34.4%) and Pulmonology (45.2%)
Departments from University Hospitals as well as Primary
Care Centers (20.4%) were enrolled in the study. Of those,
29 did not fulfill the inclusion criteria and were excluded
from the study. Reasons to be excluded were: lack of
informed consent (n= 5); absence of asthma diagnosis
(n= 1); age out of range (n= 1); has not required asthma
medication within the last month (n= 20); unstable clin-
ical condition (n= 1); recent asthma exacerbation (n= 1).
Thus, a total of 1,363 patients with asthma were included
in the analysis (Figure 1). Baseline patients’ characteristics
are depicted in Table 1. Mean age was 37.8 years, approxi-
mately 60% of the patients were women; 69% were non-
smokers; 67% lived in an urban area and 63% had no
contact with animals. The mean duration of asthma and
rhinitis was 12.9 and 13.5 years, respectively. In addition,
72.7% of the patients were atopic. Of those, 91.6% pre-
sented with rhinitis, 41.9% conjunctivitis, 16.3% atopic
dermatitis, 8.8% food allergy and 5.7% urticaria. With
regards to rhinitis, most of the patients presented mild
intermittent disease (39.4%).
Pulmonary function tests
Spirometry was conducted the day the patient was
included in the study. Results of lung function tests are
shown in Table 1. At inclusion, 64.5% of patients had a
FEV1 ≥ 80% predicted. Mean FEV1 for controlled patient
was 99.2%± 13.8 and 95.8% ± 14.9 for partially controlled
patients. Uncontrolled patient showed a mean FEV1 of
81.0%± 19.0 that was significantly lower compared to
controlled or partially controlled patients (p< 0.01).
Asthma treatment
Maintenance treatment was distributed as follows: Com-
bination of inhaled corticosteroid and long-acting β2-
agonist (75.7%), antileukotrienes (36.50%), inhaled corti-
costeroids (12.0%), allergen immunotherapy (13.0%), oral
corticosteroids (2.3%), others (8%). Percentage of patients
in each step of asthma treatment according to GINA were:
N=1392
Sampled population
N=29 excluded for not meeting all
inclusion criteria
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Figure 1 Strobe flow chart.
Olaguibel et al. Respiratory Research 2012, 13:50 Page 4 of 10
http://respiratory-research.com/content/13/1/50Step 1, 9.6%; Step 2, 11.6%; Step 3+ 4, 73%, and Step 5,
5.8%. Patients at step 3 and 4 were merged in one cat-
egory, as we do not have data about the doses of inhaled
corticosteroids.
Asthma control according to GINA 2006 guidelines and
patients’ and physicians’ perceptions
More than half of the patients (51.4%) had uncontrolled
asthma according to GINA 2006 classification (Figure 2a).
Moreover, as shown in Figure 2b, approximately half of the
patients in treatment steps 1 through 4 had uncontrolled





Age in years, median, (IQR) 38 (27–50) 37 (27–










10 (4.4 - 20) 10 (4.5
Rhinitis (% patients) 91.7 93.2
Lung function
FEV1 mean% (SD) 88.3 (18.8) 88.5 (1
FVC mean% (SD) 95.5 (19.02) 95.4 (1
FEV1/FVC mean% (SD) 76.7 (13.07) 77.2 (1perceived the disease as controlled or partially controlled,
the concordance among both groups was low (κ=0.53)
(Figure 3).
Establishment of cut-off points required to discriminate
the level of asthma control (GINA definition) using the
ACQ questionnaire
In the development population (n = 804) the cut-off
point of the ACQ questionnaire that better discrimi-
nated the controlled asthma patients was 0.5, with a sen-
sitivity of 74.1% (95%CI, 65.5-82.7) and a specificity of












-20) 10 (4–19) 0.830
90.1 0.780
9) 88.0 (18.6) 0.642
9.4) 95.7 (18.3) 0.813
3.8) 75.9 (11.5) 0.08
Figure 2 Asthma control: 2a) According to GINA 2006 guidelines and 2b) In each step of the treatment. 2a) Asthma control according to
GINA 2006 (N = 855). 2b) Asthma control according to treatment step (N = 624).
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trolled asthma patients was 1.00, with a sensitivity of
73% (95%CI, 68.7-77.5) and a specificity of 88.2% (95%
CI, 84.9-91.6) (Figure 4b).Figure 3 Perception of asthma control according to patients’
and physicians’ perceptions.Validation study
These results were validated in a subpopulation of 402
patients (Figure 1). The results in the validated population
showed a similar value for controlled asthma with a cut-off
point of 0.5 with a sensitivity of 86.1% (95%CI, 74.5-97.6).
and a specificity of 78% (95%CI, 73.6-82.4) (Figure 4a) and
a cut-off point of 1.00 for uncontrolled asthma, with a
sensitivity of 72.9% (95%CI, 66.9-78.9) and a specificity of
85.3 (95%CI, 79.8-90.8) (Figure 4b). The AUC in the devel-
opment population for controlled and uncontrolled asthma
were 0.85 (95%CI, 0.82-0.88) and 0.88 (95%CI, 0.85-0.90),
respectively p< 0.0001. In the validated population, the
AUC for controlled asthma was 0.87(95%CI, 0.82-0.93),
and for uncontrolled asthma 0.86 (95%CI 0.83-0.90)
(Figure 4 a and b). Similar results were obtained when the
simplified questionnaire (ACQ-5) was used (Figure 4c).Concordance between GINA 2006 guidelines and ACQ
scores
Kappa index between GINA categories and ACQ cut-off
points derived from the study was 0.62 (p< 0.001). As a
theoretical exercise a low concordance was found between
GINA-defined control categories and the former cut-off
ab
c
Figure 4 ACQ cut-off points obtained in the development and validation population. 4a) Uncontrolled vs.controlled. 4b) Uncontrolled vs.
partially controlled. 4c) ACQ-7 vs ACQ-5.
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et al. [14] (κappa index= 0.27).
Discussions
The recent changes in the management of asthma, based
on disease control rather that degree of severity, have
created the need of new evaluations of the current avail-
able tools for measuring asthma control. Among the
validated and standardized questionnaires are the ACQ
[13], the Asthma Control Test (ACT) [21] and Asthma
Therapy Assessment questionnaire (ATAQ) [22]. The
ACQ questionnaire was chosen in the present study be-
cause has strong evaluative and discriminative proper-
ties, is short and easy to complete and can be used with
confidence to measure asthma control in the past week,
therefore reducing the recall bias.
The results of the present study show a poor correlation
between the cut-off points described by Juniper et al. [14]
and GINA 2006 control classification. It is worth remark-
ing, however, that in the study of Juniper et al. [14] the defi-
nitions of control were based on the GOAL study [23], and
these authors grouped well-controlled and total control as
controlled, and did not attempt to distinguish between
three categories. Juniper et al. adopted the conservative
stance that “the crossover point between ‘well controlled’
and ‘not well controlled’ is close to 1.00 on the ACQ. How-
ever, to be confident that a patient has well-controlled
asthma, the optimal cut-point is 0.75 (negative predictive
value=0.85). To be confident that the patient has inad-
equately controlled asthma, the optimal cut-point is 1.50
(positive predictive value=0.88). In clinical practice, how-
ever, instead of the value 1, these authors advise that, to
make sure that most patients with inadequately controlled
asthma are not missed; the optimum cut-point is 0.75
where there is an 85% chance that his/her asthma is well
controlled [14].
Based on the calculations using the population of the
present study, the cut-off points of the ACQ questionnaire
that best agree with the levels of control proposed by
GINA 2006 are: < 0.5 for controlled asthma; 0.5 – 0.99
for partially controlled asthma, and ≥ 1 for uncontrolled
asthma. Moreover, the same cut-off points were obtained
with the simplified version of the ACQ questionnaire
(ACQ-5), which is based exclusively in clinical evaluation,
avoiding the FEV1 measurement as well as β2-agonists res-
cue use, which should facilitate its use in primary care set-
ting. It should be emphasized, however, that ACQ cut-off
points must be based on an understanding on how repre-
sentative the study population is of the population
intended to take the test. It is also worth underlying that
ACQ, and control assessment in general, is intended for
the maintenance of asthma control in the ongoing man-
agement of the disease.Similar discrepancies have been observed in different
studies where ACQ or ACT questionnaires have been
used as a predictor of GINA-defined asthma control
[8,24] . Thus, the study by Alvarez-Gutiérrez et al. [24]
found different cut-off points for ACT than previously
described (≤ 18 for uncontrolled asthma), suggesting that
a more complete assessment would require monitoring
operating parameters and FeNO. In the study published
by Thomas et al. [8], a multinational cross-sectional sur-
vey conducted in Primary Care, Pulmonology and Aller-
gology settings from France, Germany, Italy, Spain and
US, and in Primary Care and Pulmonology departments
in UK, a total of 2,949 patients filled out the ACT and
physician’s case report forms with questions related to
GINA classification without spirometry. A score of ≥20
for the ACT score defined well controlled asthma (positive
predictive value of 51.3%) while a score of≤ 19 defined
partially controlled and uncontrolled asthma (positive pre-
dictive value of 93.9%).
The study by Sastre et al. [25] also recommended the
use of different cut-off points to define well-controlled
asthma using three versions of ACQ. In addition, O’Byrne
et al. [26]., compared asthma control as assessed by the
Asthma Control Questionnaire (5-item version; ACQ-5),
Global Initiative for Asthma (GINA) or Gaining Optimal
Asthma Control (GOAL) study criteria in a retrospective
study. The results showed that patients with controlled,
partly controlled and uncontrolled asthma according to
GINA had mean ACQ-5 scores of 0.43, 0.75 and 1.62,
respectively.
However, all these studies were retrospectively
designed and not specifically developed for addressing
such correlation and, therefore, have important limita-
tions. Moreover, comparing a categorical with a continu-
ous variable is bound to give some difficulty, especially
for clinicians.
With regard to measurement of disease control, the
results also show that ACQ questionnaire is a more ac-
curate tool compared to the subjective perception of
both physicians and patients. It is also noticeable the
poor correlation found between physicians’ and patients’
perception of disease control as observed in prior studies
[27]. The information efflux fact used in the present
study, where patients completed the ACQ and min-
iAQLQ before seeing the physician, is the best way to
collect patients’ opinion avoiding the risk of physician
opinion bias.
Asthma control achieved in the present study (con-
ducted between February and July 2009) was suboptimal,
with 51.3% of patients being uncontrolled according to
GINA, despite the broad use of different treatments, as
corroborated in prior studies. In addition, some of the
prior studies have shown even worse control in winter sea-
son than in spring [9]. The present study did not take into
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were included in the study during spring season and hence
our results mainly reflect asthma control in the spring.
There is considerable room for improvement regard-
ing management of the disease from the physician per-
spective through training interventions as shown in the
study conducted by Mendez et al. [28]. In addition, pa-
tient information with regards to disease control could
and should be enhanced by providing more information
during the doctor’s visit. In primary care settings several
studies show that ACQ seems to be a useful starting
point for health care professionals in family practice to
improve the level of asthma symptom control in their
patient population [29].
When analyzing the asthma treatment prescribed to the
patients in the present study, is surprising the high percen-
tages of patients classified as having GINA-defined uncon-
trolled disease (52.3%), and those receiving combination
treatment (78.8% were on step 3 or higher). The results
confirm the low degree of asthma control in Spain, which
may be due to several factors, including low degree of im-
plementation and compliance with asthma management
guidelines, poor adherence to asthma treatments [30],
among others. However, it should also be considered that
the GINA scale to identify controlled, partially controlled
or uncontrolled asthma was developed based on expert
opinion and is not validated. Controlled asthma, as defined
in GINA, is quite similar to “totally controlled” asthma
defined in the GOAL study [23], and this turns out to be a
maximal therapeutic goal that is difficult to achieve for
many patients. GINA-defined “partially controlled” is a
more reasonable therapeutic goal. Interestingly, a retro-
spective analysis of three clinical trials with combination
therapy showed that controlled and partly controlled
asthma by GINA criteria are comparable to an ACQ-5
score of <1 [26]. Our study reinforces this finding, with the
strength that it was analyzed prospectively in a clinical prac-
tice setting.
Although participant physicians were mainly in specia-
lized settings (79.6% from Allergy and Pulmonology set-
tings vs. 20.4% from primary care), the same results
regarding asthma control were obtained when the ana-
lysis was stratified by this variable (data not shown). This
homogeneity in the results is noticeable because the se-
verity of the disease of the patients seen in the three
physician groups is different, according to published epi-
demiological studies [31].
In conclusion, the results of the present study provide
new cut-off points for ACQ questionnaire with a better
agreement to the asthma control classification proposed
by GINA 2006, which can be applied to asthmatic patients
in clinical practice. Finally, the short version of the ACQ
(ACQ-5), measures very easily the degree of asthma con-
trol in primary care as well other specialized settings.Competing interest
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